ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

33,411Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 6645

$3.47M Total Retail Price of All Prescriptions

Rank: 19 out of 6645

657 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 657 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 32,093 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

55% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$104 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
CRESTOR 1,261 1,233 1 34
METOPROLOL SUCCINATE 826 807 2 24
NEXIUM 714 701 3 40
DONEPEZIL HCL 640 634 4 27
CELEBREX 623 612 5 54
OMEPRAZOLE 588 570 6 6
DEXILANT 570 524 7 102
BENICAR 564 558 8 84
VOLTAREN 559 553 9 108
TAMSULOSIN HCL 543 527 10 22
ATORVASTATIN CALCIUM 531 509 11 10
SIMVASTATIN 528 488 12 1
BENICAR HCT 525 511 10 13 158
CYMBALTA 497 457 14 78
TRAMADOL HCL 487 477 15 30
ZOLPIDEM TARTRATE 485 461 16 17
LOVAZA 461 457 17 68
PRAVASTATIN SODIUM 451 432 18 20
GABAPENTIN 418 407 19 18
PRAMIPEXOLE DIHYDROCHLORIDE 406 406 10 20 222
ESCITALOPRAM OXALATE 405 387 21 86
METFORMIN HCL 399 372 22 7
LEVOTHYROXINE SODIUM 384 376 23 4
ALENDRONATE SODIUM 374 364 24 14
NAMENDA 363 363 25 41
FUROSEMIDE 363 355 25 11
ALLOPURINOL 355 342 27 31
MELOXICAM 354 353 28 46
ZETIA 334 306 29 87
PLAVIX 330 330 30 49
AMLODIPINE BESYLATE 326 319 31 2
ATENOLOL 316 295 32 8
BYSTOLIC 308 305 33 110
VESICARE 305 305 34 148
TRIAMCINOLONE ACETONIDE 264 237 35 55
AZOR 263 261 36 152
ULORIC 261 253 10 37 227
ISOSORBIDE MONONITRATE ER 261 247 37 66
LEVOFLOXACIN 250 236 39 83
CARVEDILOL 247 247 40 25
PRIMIDONE 242 242 41 372
LEXAPRO 229 208 42 218
LIPITOR 228 227 43 69
SINGULAIR 224 220 44 76
GLIMEPIRIDE 217 203 45 47
CREON 216 215 46 114
BUPROPION XL 210 198 47 225
ADVAIR DISKUS 209 206 48 45
EFFIENT 206 183 49 261
CLOPIDOGREL 203 202 50 36
SYNTHROID 198 195 51 79
JANUVIA 197 194 52 38
SPIRONOLACTONE 189 174 53 85
SPIRIVA 180 180 54 65
FORTEO 179 173 55 280
NASONEX 173 170 56 126
DIOVAN 171 171 57 19
PANTOPRAZOLE SODIUM 168 154 58 29
BONIVA 167 128 59 191
SERTRALINE HCL 165 151 60 43
TRIBENZOR 164 151 61 257
SYMBICORT 163 163 62 153
AMITIZA 159 158 63 245
LANSOPRAZOLE 158 155 64 163
AVODART 154 154 65 99
ACTONEL 151 150 66 92
WELCHOL 151 147 66 199
IBANDRONATE SODIUM 145 136 68 147
LYRICA 144 134 69 127
BUSPIRONE HCL 143 143 70 207
HYDROCHLOROTHIAZIDE 141 130 71 9
ACTOS 137 123 72 71
ECONAZOLE NITRATE 137 136 72 263
DIGOXIN 132 132 74 59
WARFARIN SODIUM 131 129 75 16
NAPROXEN 126 99 76 88
PATADAY 124 120 77 183
TRIAMTERENE-HCTZ 121 117 78 52
EVISTA 120 113 79 90
IBUPROFEN 119 107 80 42
METOPROLOL TARTRATE 119 113 80 13
SAVELLA 119 112 80 570
AZITHROMYCIN 118 110 83 44
PROPRANOLOL HCL 111 103 84 151
FAMOTIDINE 107 100 85 33
MICARDIS 105 105 86 232
OXYBUTYNIN CHLORIDE ER 104 96 87 179
NIASPAN 101 100 88 164
GLYBURIDE-METFORMIN HCL 101 97 R 88 95
JANUMET 100 95 90 132
HYDROCODONE-ACETAMINOPHEN 100 73 S3 90 5
MECLIZINE HCL 100 97 90 122
RANEXA 99 90 93 276
NATEGLINIDE 98 87 94 220
AMITRIPTYLINE HCL 97 96 R 95 117
PRADAXA 97 97 95 247
ACIPHEX 95 94 97 167
AMLODIPINE BESYLATE-BENAZEPRIL 92 91 98 97
PROAIR HFA 90 89 99 32
TRAZODONE HCL 89 87 100 60
ZENPEP 89 89 100 210
VYTORIN 86 86 102 170
DIOVAN HCT 85 83 103 64
PEN NEEDLE 83 77 104 159
MICARDIS HCT 82 82 105 299
FLUTICASONE PROPIONATE 82 82 105 26
NITROSTAT 81 81 107 193
LOSARTAN POTASSIUM 81 81 107 12
CITALOPRAM HBR 77 77 109 35
LOSARTAN-HYDROCHLOROTHIAZIDE 75 65 110 62
MONTELUKAST SODIUM 74 72 111 128
POTASSIUM CHLORIDE 72 72 112 28
CIPROFLOXACIN HCL 72 69 112 67
PRISTIQ ER 70 70 114 474
VICTOZA 3-PAK 70 53 114 365
FINASTERIDE 69 69 116 73
CLONIDINE HCL 68 68 117 56
VENTOLIN HFA 68 68 117 146
CARBIDOPA-LEVODOPA 68 68 117 116
FLECTOR 68 68 117 230
CICLOPIROX 67 65 121 402
AMIODARONE HCL 67 67 121 160
PAROXETINE HCL 67 67 121 72
VENLAFAXINE HCL ER 67 57 121 175
RANITIDINE HCL 66 64 125 51
XARELTO 65 63 126 435
FENOFIBRATE 63 63 127 74
VERAPAMIL ER 61 61 128 154
COLCRYS 58 55 129 192
ARICEPT 57 57 130 442
QUETIAPINE FUMARATE 56 56 131 101
RAPAFLO 56 56 131 246
ATELVIA 55 55 133 91
JALYN 55 55 133 354
ALCOHOL PREP PADS 54 53 135 330
LEVOXYL 54 43 135 136
CILOSTAZOL 52 52 137 202
PROCHLORPERAZINE MALEATE 52 52 137 347
HYDROXYZINE HCL 52 52 R 137 161
POLYETHYLENE GLYCOL 3350 51 40 140 121
DICLOFENAC SODIUM 51 51 140 109
PATANOL 50 41 142 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.